Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;33(5):372-378.
doi: 10.1111/tme.12993. Epub 2023 Sep 5.

Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP

Victoria Maddox  1 , Pamela Vallely  2 , Susan R Brailsford  1 , Heli Harvala  1
Affiliations
Review

Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP

Victoria Maddox et al. Transfus Med. 2023 Oct.

Abstract

A more individualised donor selection policy was implemented in the UK in 2021, which replaced the previous 3-month deferral for men who have sex with men (MSM). Other blood services have a variety of policies in place to ensure the virological safety of blood components, ranging from an indefinite ban on MSM, to a defined period of exclusion, or to an individualised risk assessment that is not based on gender or sexual orientation. Justification of these policies should be based on scientific evidence including assessment of lengths of virological window periods, infectious disease epidemiology within donor populations and donation screening assay sensitivities. Developments in molecular technology and assays which can detect both antibodies and antigens in the very early stages of infection have significantly reduced the risk in most developed countries. However, the increasing usage of pre-exposure prophylaxis (PrEP) to prevent acquisition of HIV infection after possible high-risk sexual contact within the UK blood donor population has been recently noted. It has brought with it new diagnostic challenges within blood screening, notably possible non-detection of HIV RNA and serological markers following PrEP use despite potential infectivity. The use of other testing strategies such as detection of HIV DNA and screening for non-declared PrEP usage should be investigated further.

Keywords: HIV; PrEP; blood donation; blood safety; donor deferral.

PubMed Disclaimer

References

REFERENCES

    1. Dwyre DM, Fernando LP, Holland PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang. 2011;100(1):92-98. doi:10.1111/j.1423-0410.2010.01426.x
    1. Byrne L, Brant LJ, Davison K, Hewitt P. Transfusion-transmitted human immunodeficiency virus (HIV) from seroconverting donors is rare in England and Wales: results from HIV lookback, October 1995 through December 2008. Transfusion. 2011;51(6):1339-1345. doi:10.1111/j.1537-2995.2010.02996.x
    1. Lambert G, Cox J, Fourmigue A, et al. HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: informing blood donor selection criteria in Canada. Transfusion. 2022 Oct 5;62:2555-2567. doi:10.1111/trf.17127
    1. Lelie N, Busch M, Kleinman S. Efficacy of different testing scenarios in reducing transfusion-transmitted hepatitis B virus (TT-HBV) infection risk. Viruses. 2022;14(10):2263. doi: 10.3390/v14102263
    1. Serious Hazards of Transfusion (SHOT) Steering Group. SHOT report. 2021.

Substances

LinkOut - more resources